Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Utility of blood lactate level in triage.

Fukumoto Y, Inoue Y, Takeuchi Y, Hoshino T, Nakamura Y, Ishikawa K, Morikawa M, Suginaka H, Sueyoshi K, Sumi Y, Matsuda S, Okamoto K, Tanaka H.

Acute Med Surg. 2015 Aug 17;3(2):101-106. doi: 10.1002/ams2.130. eCollection 2016 Apr.

2.

Hospital disaster response using business impact analysis.

Suginaka H, Okamoto K, Hirano Y, Fukumot Y, Morikawa M, Oode Y, Sumi Y, Inoue Y, Matsuda S, Tanaka H.

Prehosp Disaster Med. 2014 Dec;29(6):561-8. doi: 10.1017/S1049023X14001022. Epub 2014 Sep 30.

PMID:
25269077
3.

An unusual case of common digital nerve compression caused by a lipoma arising from the flexor tenosynovium.

Suginaka H, Hara A, Kudo T.

Hand Surg. 2013;18(3):435-7. doi: 10.1142/S0218810413720337. Review.

PMID:
24156595
4.

Mutation analysis of the histidine residues in the glycylglycine endopeptidase ALE-1.

Fujiwara T, Aoki S, Komatsuzawa H, Nishida T, Ohara M, Suginaka H, Sugai M.

J Bacteriol. 2005 Jan;187(2):480-7.

5.

Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria.

Yamano R, Ohara M, Nishikubo S, Fujiwara T, Kawamoto T, Ueno Y, Komatsuzawa H, Okuda K, Kurihara H, Suginaka H, Oswald E, Tanne K, Sugai M.

J Clin Microbiol. 2003 Apr;41(4):1391-8.

6.

Modification of autolysis by synthetic peptides derived from the presumptive binding domain of Staphylococcus aureus autolysin.

Takano M, Oshida T, Yasojima A, Yamada M, Okagaki C, Sugai M, Suginaka H, Matsushita T.

Microbiol Immunol. 2000;44(6):463-72.

7.

Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus.

Komatsuzawa H, Ohta K, Sugai M, Fujiwara T, Glanzmann P, Berger-BächiB, Suginaka H.

J Antimicrob Chemother. 2000 Apr;45(4):421-31.

8.

Identification of a fmtA-like gene that has similarity to other PBPs and beta-lactamases in Staphylococcus aureus.

Komatsuzawa H, Choi GH, Fujiwara T, Huang Y, Ohta K, Sugai M, Suginaka H.

FEMS Microbiol Lett. 2000 Jul 1;188(1):35-9.

9.

Triton X-100-induced lipoteichoic acid release is correlated with the methicillin resistance in Staphylococcus aureus.

Ohta K, Komatsuzawa H, Sugai M, Suginaka H.

FEMS Microbiol Lett. 2000 Jan 1;182(1):77-9.

10.

Effect of clarithromycin on Pseudomonas aeruginosa biofilms.

Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T.

Chemotherapy. 2000 Jan-Feb;46(1):36-42.

PMID:
10601796
11.

Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1.

Sugai M, Hatazaki K, Mogami A, Ohta H, Pérès SY, Hérault F, Horiguchi Y, Masuda M, Ueno Y, Komatsuzawa H, Suginaka H, Oswald E.

Infect Immun. 1999 Dec;67(12):6550-7.

12.

Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureus.

Komatsuzawa H, Ohta K, Labischinski H, Sugai M, Suginaka H.

Antimicrob Agents Chemother. 1999 Sep;43(9):2121-5.

13.

Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells.

Sakata M, Shiba H, Komatsuzawa H, Fujita T, Ohta K, Sugai M, Suginaka H, Kurihara H.

J Bone Miner Res. 1999 Sep;14(9):1486-92.

14.

Cloning and characterization of a gene, pbpF, encoding a new penicillin-binding protein, PBP2B, in Staphylococcus aureus.

Komatsuzawa H, Choi GH, Ohta K, Sugai M, Tran MT, Suginaka H.

Antimicrob Agents Chemother. 1999 Jul;43(7):1578-83.

15.

Cloning of the gene encoding the Actinobacillus actinomycetemcomitans serotype b OmpA-like outer membrane protein.

Komatsuzawa H, Kawai T, Wilson ME, Taubman MA, Sugai M, Suginaka H.

Infect Immun. 1999 Feb;67(2):942-5.

16.

Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones.

Tanaka G, Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T.

Chemotherapy. 1999 Jan-Feb;45(1):28-36.

PMID:
9876207
17.

Expression analysis of the autolysin gene (atl) of Staphylococcus aureus.

Oshida T, Takano M, Sugai M, Suginaka H, Matsushita T.

Microbiol Immunol. 1998;42(9):655-9.

18.

The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Sugai M, Kawamoto T, Pérès SY, Ueno Y, Komatsuzawa H, Fujiwara T, Kurihara H, Suginaka H, Oswald E.

Infect Immun. 1998 Oct;66(10):5008-19.

19.

The mechanism of sensitizing effect of a triazine dye, cibacron blue F3GA, on methicillin-resistant Staphylococcus aureus to oxacillin.

Shirai C, Sugai M, Komatsuzawa H, Ohta K, Yamakido M, Suginaka H.

Hiroshima J Med Sci. 1998 Jun;47(2):73-83.

PMID:
9674344
20.

A triazine dye, cibacron blue F3GA, decreases oxacillin resistance levels in methicillin-resistant Staphylococcus aureus.

Shirai C, Sugai M, Komatsuzawa H, Ohta K, Yamakido M, Suginaka H.

Antimicrob Agents Chemother. 1998 May;42(5):1278-80.

21.

Effect of adherence on antimicrobial susceptibility of Pseudomonas aeruginosa, Serratia marcescens, and Proteus mirabilis.

Fujiwara S, Miyake Y, Usui T, Suginaka H.

Hiroshima J Med Sci. 1998 Mar;47(1):1-5.

PMID:
9583277
22.

High incidence of Staphylococcus aureus from dentures and tongues of maxillary resection patients.

Matsuura T, Kohada A, Yamamoto T, Miyake Y, Akagawa Y, Suginaka H, Tsuru H.

Oral Microbiol Immunol. 1997 Dec;12(6):354-7.

PMID:
9573810
23.

Zymographic characterization of Staphylococcus aureus cell wall.

Ohta K, Komatsuzawa H, Sugai M, Suginaka H.

Microbiol Immunol. 1998;42(3):231-5.

24.

Expression and purification of epidermal cell differentiation inhibitor (EDIN) from Bacillus subtilis.

Hatazaki K, Sugai M, Momota H, Ohgai H, Komatsuzawa H, Suginaka H.

Protein Expr Purif. 1998 Mar;12(2):284-90.

PMID:
9518471
25.

Cloning and characterization of the fmt gene which affects the methicillin resistance level and autolysis in the presence of triton X-100 in methicillin-resistant Staphylococcus aureus.

Komatsuzawa H, Sugai M, Ohta K, Fujiwara T, Nakashima S, Suzuki J, Lee CY, Suginaka H.

Antimicrob Agents Chemother. 1997 Nov;41(11):2355-61.

26.

Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method.

Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T.

Chemotherapy. 1997 Sep-Oct;43(5):340-5.

PMID:
9309367
27.

Effects of various types of Triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillin.

Suzuki J, Komatsuzawa H, Sugai M, Ohta K, Kozai K, Nagasaka N, Suginaka H.

FEMS Microbiol Lett. 1997 Aug 15;153(2):327-31.

29.

Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus.

Sugai M, Yamada S, Nakashima S, Komatsuzawa H, Matsumoto A, Oshida T, Suginaka H.

J Bacteriol. 1997 May;179(9):2958-62.

30.

[Bacteriolytic enzymes produced by the staphylococci].

Sugai M, Suginaka H.

Nihon Saikingaku Zasshi. 1997 Apr;52(2):461-73. Review. Japanese. No abstract available.

PMID:
9155203
31.

Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents.

Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T.

Chemotherapy. 1997 Mar-Apr;43(2):137-41.

PMID:
9084923
32.

Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1.

Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, Inoue S, Suginaka H.

J Bacteriol. 1997 Feb;179(4):1193-202.

33.

A long-term survey of methicillin-resistant Staphylococcus aureus in the oral cavity of children.

Suzuki J, Komatsuzawa H, Sugai M, Suzuki T, Kozai K, Miyake Y, Suginaka H, Nagasaka N.

Microbiol Immunol. 1997;41(9):681-6.

34.

Subcellular localization of the major autolysin, ATL and its processed proteins in Staphylococcus aureus.

Komatsuzawa H, Sugai M, Nakashima S, Yamada S, Matsumoto A, Oshida T, Suginaka H.

Microbiol Immunol. 1997;41(6):469-79.

35.

An autolysin ring associated with cell separation of Staphylococcus aureus.

Yamada S, Sugai M, Komatsuzawa H, Nakashima S, Oshida T, Matsumoto A, Suginaka H.

J Bacteriol. 1996 Mar;178(6):1565-71.

36.

Isolation and characterization of teichoic acid-lake substance as an adhesin of Staphylococcus aureus to HeLa cells.

Matsuura T, Miyake Y, Nakashima S, Komatsuzawa H, Akagawa Y, Suginaka H.

Microbiol Immunol. 1996;40(4):247-54.

37.

Triton X-100 alters the resistance level of methicillin-resistant Staphylococcus aureus to oxacillin.

Komatsuzawa H, Sugai M, Shirai C, Suzuki J, Hiramatsu K, Suginaka H.

FEMS Microbiol Lett. 1995 Dec 15;134(2-3):209-12.

PMID:
8586269
38.

In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.

Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H.

J Periodontal Res. 1995 Jul;30(4):290-3.

PMID:
7562327
39.

Microbiological features of gingivitis in pubertal children.

Tsuruda K, Miyake Y, Suginaka H, Okamoto H, Iwamoto Y.

J Clin Periodontol. 1995 Apr;22(4):316-20.

PMID:
7622639
40.

Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus.

Sugai M, Komatsuzawa H, Akiyama T, Hong YM, Oshida T, Miyake Y, Yamaguchi T, Suginaka H.

J Bacteriol. 1995 Mar;177(6):1491-6.

41.
42.

Alteration of bacteriolytic enzyme profile of Staphylococcus aureus during growth.

Komatsuzawa H, Sugai M, Nakashima S, Suginaka H.

Microbiol Immunol. 1995;39(8):629-33.

43.

The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillin.

Komatsuzawa H, Suzuki J, Sugai M, Miyake Y, Suginaka H.

J Antimicrob Chemother. 1994 Dec;34(6):885-97.

PMID:
7730232
44.

Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.

Komatsuzawa H, Suzuki J, Sugai M, Miyake Y, Suginaka H.

J Antimicrob Chemother. 1994 Jun;33(6):1155-63.

PMID:
7928809
45.

Isolation and characterization of Staphylococcus aureus mutants which form altered cell clusters.

Sugai M, Komatsuzawa H, Ooku-Inomata K, Miyake Y, Ishida E, Suginaka H.

Microbiol Immunol. 1994;38(12):995-9.

46.

Effects of cefuzonam on peptidoglycan cross-linking reactions in gram-negative bacilli.

Miyake Y, Okada M, Iseda S, Suginaka H.

Chemotherapy. 1992;38(1):17-20.

PMID:
1617999
47.

Simple method for measuring the antibiotic concentration required to kill adherent bacteria.

Miyake Y, Fujiwara S, Usui T, Suginaka H.

Chemotherapy. 1992;38(5):286-90.

PMID:
1286571
48.

Mechanism of aminoglycoside enhancement of Staphylococcus aureus adherence to HeLa cells.

Miyake Y, Kohada A, Sugai M, Suginaka H.

J Antimicrob Chemother. 1991 Dec;28(6):811-7.

PMID:
1816179
49.

Incidence and characterization of Staphylococcus aureus from the tongues of children.

Miyake Y, Iwai T, Sugai M, Miura K, Suginaka H, Nagasaka N.

J Dent Res. 1991 Jul;70(7):1045-7.

PMID:
2066485
50.

Supplemental Content

Loading ...
Support Center